Evidence hub

Chronic Wounds & Ulcers: cell-therapy evidence by therapy class

Across every stem-cell intervention, ClinicalTrials.gov holds 53 registered records for Chronic Wounds & Ulcers — 3 recruiting, 7 at Phase 3 or 4, in 17 countries. Snapshot 2026-08-29.

Medical review statusMedically reviewedReviewed by: Stem Plus medical teamReviewed on: 2026-08-29Last evidence update: 2026-08-29Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

The condition, and why cells are proposed

The registry entries here centre on diabetic foot ulcers, where impaired healing reflects neuropathy, ischaemia and infection together. Cell and vesicle products aim to restore a functional healing environment. This is one of the few areas with a genuine regulatory precedent for advanced wound products, so evidence standards are comparatively well defined.

Therapy classes side by side

Therapy classRegisteredRecruitingPhase 3/4Countries
MSC311211
HSCT1011
exosomes3003
PRP262310

Counts come from separate registry queries per class; a study testing two interventions can appear in more than one row, so rows do not sum to the all-interventions total.

Geography of the research

United States accounts for about 33% of country mentions among sampled studies; 17 countries host at least one site.

CountryStudies with a site there
United States13
China11
South Korea4
Germany3
Spain2
Israel2
Turkey (Türkiye)1
Australia1

The largest registered studies

Sorted by planned enrolment — size is not quality, but a 300-participant trial can answer questions a 12-participant series cannot.

StudyPhaseStatusPlanned nLead sponsorStart
NCT02796079 — A Clinical Study Using Autologous Bone Marrow Stem Cell for Diabetes Related Vascular ComplicationsPhase 1Unknown240Jie Shen2015-01
NCT02831075 — A Clinical Study Using Adipose-derived Stem Cells for Diabetic FootPhase 1Unknown240Jie Shen2015-01
NCT02834858 — Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular ComplicationsPhase 1Unknown240Jie Shen2016-01
NCT06681428 — Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcersn/aRecruiting240Tides Medical2024-11-14
NCT04176120 — Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)Phase 3Completed220BioTissue Holdings, Inc2020-07-01
NCT02264288 — Efficacy and Safety of Intramuscular PDA-002 in Subjects With Diabetic Foot Ulcer With and Without PAD.Phase 2Terminated159Celularity Incorporated2014-10-23

Most recently registered

StudyPhaseStatusPlanned nLead sponsorStart
NCT07686094 — Placental Cells for Diabetic Foot Ulcersn/aNot Yet Recruitingn/aWake Forest University Health Sciences2026-10
NCT07498218 — Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissuen/aRecruitingn/aAyu, Inc.2026-03-11
NCT06843122 — Evaluation of the Safety and Efficacy of Live ASCs in the Treatment of Diabetic Foot (FOOTCELL)n/aNot Yet Recruitingn/aMedical University of Warsaw2025-03-08
NCT06846476 — The Effect of Using Insoles Specially Designed for Diabetic Foot on Postural Balance and Gait Parametersn/aCompletedn/aMedipol University2024-12-24
NCT06681428 — Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcersn/aRecruitingn/aTides Medical2024-11-14

Reading this honestly

Registration counts measure activity, not effect. A study appears here the moment it is registered — before any participant is enrolled, and regardless of whether results are ever posted. For Chronic Wounds & Ulcers specifically, the practical question is which registered study — if any — matches the product a provider is offering, and what its outcome measures actually are.

Frequently asked

How many stem-cell trials exist for Chronic Wounds & Ulcers?

53 registered records mention a stem-cell intervention for this condition (2026-08-29 snapshot), of which 3 were recruiting.

Which therapy class is furthest along for Chronic Wounds & Ulcers?

Ranked by Phase 3/4 records: PRP (3), MSC (2), HSCT (1), exosomes (0).

Does a recruiting trial mean I can be treated?

No. Trials have eligibility criteria, and joining one is not the same as buying a treatment. Paying a clinic for an unproven intervention outside a registered study gives you neither the protections nor the data collection of a trial.

Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.

Explore all sections · Data & downloads

Download the query data

Download CSV · Download JSON

Query totals are full API matches; status, phase and country counts describe the first up to 400 returned records per query. Query classes overlap and must not be summed as unique trials. Counts are not treatment outcomes. Snapshot: 2026-08-29. Methods and field definitions.